Inc Xencor serves as Executive at Inmune Bio, Inc., where they oversee executive responsibilities. Since joining the company, Inc Xencor has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 3, 2021 involved exercising options for 108,000 shares valued at $842.4K.
Inc Xencor currently holds 1,885,533 shares of Inmune Bio, Inc. (INMB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Inc Xencor has been a net neutral trader of INMB stock. They have purchased $0 and sold $0 worth of shares.
Inc Xencor's most recent insider trade was on Sep 3, 2021, when they sold 108,000 shares at $7.80 per share.
Get notified when new Form 4 filings are submitted
| 192,533 |
| $17.14 |
| Discretionary |
| Jun 10, 2021 | INMB | $3.3M | Other | 192,533 | $17.14 | Discretionary |
| Jun 10, 2021 | INMB | $3.3M | Other | 192,532 | $17.14 | Discretionary |